“The health care and life sciences industries are in transition from reactive and largely episodic models of care that are proving increasingly costly and inefficient to operate, to care models that are proactive, digitally-enabled and deliver better value for patients.
Medtech companies and the IoMT can capitalise on the possibilities presented by these changes to help to connect patients, providers and payers and enable them all to become more patient centric, productive and cost effective. The industry faces a number of systemic challenges and opportunities that needs to be addressed for the full value of the IoMT to be realised. These include:
The presentation will focus on international case studies where IoMT has successfully been implemented.
Medtech, Internet of Medical Things (IoMT), Clinical Advantage, Broader Value Creation, Operating Leverage